Intra-Gastric Balloons Market
By Product Type;
Single Intra-gastric Balloons, Dual Intra-gastric Balloons, and Triple Intra-gastric BalloonsBy Filling Materials;
Saline Filled Balloons and Gas Filled BalloonsBy End User;
Hospitals, Ambulatory Surgical Centers, and ClinicsBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Intra-Gastric Balloons Market Overview
Intra-Gastric Balloons Market (USD Million)
Intra-Gastric Balloons Market was valued at USD 52.64 million in the year 2024. The size of this market is expected to increase to USD 171.72 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 18.4%.
Intra-Gastric Balloons Market
*Market size in USD million
CAGR 18.4 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 18.4 % |
Market Size (2024) | USD 52.64 Million |
Market Size (2031) | USD 171.72 Million |
Market Concentration | Low |
Report Pages | 357 |
Major Players
- Allurion Technologies
- Apollo Endosurgery
- Districlass Medical
- Helioscopie Medical Implants
- Silimed
- Medsil
- Obalon Therapeutics
- ReShape Medical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Intra-Gastric Balloons Market
Fragmented - Highly competitive market without dominant players
The Intra-Gastric Balloons Market is gaining strong momentum as more individuals opt for non-invasive weight loss procedures. Over 60% of patients are now favoring non-surgical methods, leading to growing interest in balloon-based treatments. The method’s reversible nature and low complication risks create vast opportunities for expanding healthcare offerings and enhancing patient satisfaction.
Evolving Technologies Transforming Treatment Outcomes
Innovations in intra-gastric balloon devices are boosting efficiency and patient results. With around 55% of products now featuring adjustable inflation levels and advanced biomaterials, manufacturers are improving both comfort and effectiveness. These technological advancements are instrumental in shaping a more scalable and patient-friendly market, driving continuous growth.
Collaborative Pathways Enhancing Reach and Adoption
The increasing trend of collaboration among healthcare firms is helping to streamline product development. Approximately 52% of new introductions are emerging from joint efforts between medical developers and research centers. These strategic partnerships allow for quicker approvals, better user training, and wider market accessibility, resulting in strengthened commercial strategies.
Investment Trends Indicating Positive Market Outlook
Strong interest from investors, with over 50% prioritizing weight-loss interventions, signals a bright future for the Intra-Gastric Balloons Market. The wave of mergers and acquisitions is also reshaping the competitive landscape, fostering innovation and accelerating scaling opportunities. As interest continues to surge, the market is poised for long-term success and sustained development.
Intra-Gastric Balloons Market Recent Developments
-
October 2022: Allurion received approval to launch its revolutionary gastric balloon technology in Brazil. The Allurion Balloon, known in Brazil as the Elipse Balloon, is the first and only intragastric weight-loss balloon that is routinely placed and removed without surgery, endoscopy, or anesthesia.
-
September 2022: Allurion launched its swallowable gastric balloon capsule for weight loss in India. Allurion launched a complete weight loss program in India that includes the Allurion Swallowable Capsule, the Allurion Virtual Care Suite, a remote patient monitoring solution powered by the Allurion Iris AI platform that includes the Allurion Mobile App, Connected Scale, and Health Tracker.
Intra-Gastric Balloons Market Segment Analysis
In this report, the Intra-Gastric Balloons Market has been segmented by Product Type, Filling Materials, End User, and Geography.
Intra-Gastric Balloons Market, Segmentation by Product Type
The Intra-Gastric Balloons Market has been segmented by Product Type into Single Intra-gastric Balloons, Dual Intra-gastric Balloons, and Triple Intra-gastric Balloons.
Single Intra-gastric Balloons
Single intra-gastric balloons dominate the market with a share of approximately 60%. These are widely used for temporary weight loss procedures due to their ease of placement, cost-effectiveness, and proven safety profile. They are particularly suitable for mild to moderate obesity management in outpatient settings.
Dual Intra-gastric Balloons
Dual intra-gastric balloons represent nearly 25% of the market and offer enhanced stomach volume occupancy, leading to improved satiety control and better weight loss outcomes. These devices are preferred for patients with higher BMI seeking non-surgical interventions with greater efficacy than single-balloon systems.
Triple Intra-gastric Balloons
Triple intra-gastric balloons hold about 15% of the market and are primarily used in advanced bariatric programs. Their design allows for maximum gastric space filling, making them ideal for severe obesity cases. While more complex to administer, they offer superior appetite suppression and weight management benefits.
Intra-Gastric Balloons Market, Segmentation by Filling Materials
The Intra-Gastric Balloons Market has been segmented by Filling Materials into Saline Filled Balloons and Gas Filled Balloons.
Saline Filled Balloons
Saline filled balloons lead the Intra-Gastric Balloons Market with an estimated share of 65%. These devices are widely used due to their proven safety, radiographic visibility, and higher density, which enhances satiety. Their ability to trigger a stronger feeling of fullness makes them highly effective for moderate to significant weight loss.
Gas Filled Balloons
Gas filled balloons account for approximately 35% of the market. They are known for being lighter in weight and more comfortable for patients, often resulting in fewer side effects like nausea or discomfort. These balloons are increasingly used in ambulatory care due to their non-invasive placement and better tolerance rates.
Intra-Gastric Balloons Market, Segmentation by End User
The Intra-Gastric Balloons Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, and Clinics.
Hospitals
Hospitals dominate the Intra-Gastric Balloons Market with a share of approximately 55%. They are the preferred setting for complex weight loss procedures due to access to specialized bariatric teams, advanced surgical equipment, and post-operative monitoring. Hospitals are also better equipped to manage high-risk obesity cases.
Ambulatory Surgical Centers
Ambulatory Surgical Centers (ASCs) account for nearly 30% of the market. These facilities offer cost-effective, same-day procedures with reduced hospital stay, making them attractive for patients seeking minimally invasive weight loss treatments. ASCs are gaining popularity due to shorter recovery times and enhanced patient convenience.
Clinics
Clinics hold about 15% of the market and are typically involved in initial consultations, balloon placement follow-ups, and weight management counseling. Their role in providing personalized care and long-term lifestyle support is essential in ensuring the sustainability of weight loss outcomes.
Intra-Gastric Balloons Market, Segmentation by Geography
In this report, the Intra-Gastric Balloons Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
Intra-Gastric Balloons Market Share (%), by Geographical Region
North America
North America leads the Intra-Gastric Balloons Market with a share of approximately 40%. High obesity prevalence, advanced healthcare infrastructure, and growing awareness of non-surgical weight loss options drive regional demand. The U.S. remains the key contributor due to its strong bariatric care network and regulatory approvals.
Europe
Europe accounts for nearly 30% of the market, supported by an increasing number of weight management programs and a well-established network of specialty obesity clinics. Countries like Germany, the UK, and France are leading in the adoption of intra-gastric balloon procedures.
Asia Pacific
Asia Pacific holds around 18% of the market and is experiencing rapid growth due to rising obesity rates, increasing disposable incomes, and improving access to bariatric treatments. Emerging markets such as India, China, and South Korea are showing strong adoption potential.
Middle East & Africa
This region contributes approximately 7% to the global market. Urbanization, changing lifestyles, and a growing demand for minimally invasive weight loss solutions are supporting market growth. However, limited access to advanced care in rural areas remains a challenge.
Latin America
Latin America holds close to 5% of the market share. Countries such as Brazil and Mexico are witnessing increased demand for non-invasive obesity treatments due to rising obesity prevalence and public health initiatives aimed at improving metabolic health outcomes.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Intra-Gastric Balloons Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Minimally invasive procedures
- Rising awareness
- Non-surgical weight loss
-
Increasing healthcare expenditure -The global intra-gastric balloons market is experiencing growth fueled by increasing healthcare expenditure worldwide. As countries allocate more resources to healthcare, there's a corresponding rise in demand for advanced medical interventions to address conditions like obesity and its associated comorbidities. Intra-gastric balloons, being a minimally invasive and effective treatment option for weight management, are witnessing heightened adoption.
With rising healthcare expenditure, there's greater accessibility to healthcare services, including bariatric procedures like intra-gastric balloon placement. This accessibility enables a larger population to seek treatment for obesity, driving market growth.
Increased healthcare spending often correlates with advancements in medical technology and infrastructure. This translates to improved healthcare facilities, better-trained medical professionals, and enhanced patient care pathways for procedures like intra-gastric balloon insertion and follow-up.
Healthcare expenditure grows, there's a parallel emphasis on preventive healthcare measures. Intra-gastric balloons are not only used for weight loss but also for managing obesity-related conditions like diabetes and hypertension. This preventive approach aligns with healthcare strategies aimed at reducing the burden of chronic diseases, further boosting the demand for intra-gastric balloons.
Higher healthcare spending facilitates research and development activities in the medical field. This leads to innovations in intra-gastric balloon technology, such as the development of safer materials, improved designs, and enhanced efficacy, driving market expansion.
In conclusion, the increasing healthcare expenditure globally is a significant driver for the growth of the intra-gastric balloons market. It fosters accessibility to healthcare services, supports advancements in medical technology, promotes preventive healthcare measures, and stimulates innovation, all of which contribute to the expanding adoption of intra-gastric balloons for weight management and related conditions.
Restraints:
- Limited Reimbursement
- Temporary Weight Loss
- Patient Selection Criteria
-
High Costs -The global intra-gastric balloons market faces challenges related to high costs, which can impact accessibility and adoption rates. The initial cost of acquiring and implanting intra-gastric balloons, along with associated medical procedures and follow-up care, can be significant, making them inaccessible to certain segments of the population.
High costs may deter some patients from considering intra-gastric balloons as a viable option for weight management, especially in regions where healthcare expenses are a burden or insurance coverage is limited. This disparity in access can exacerbate existing inequalities in healthcare and limit the reach of this potentially beneficial intervention.
The high costs associated with intra-gastric balloons may pose financial challenges for healthcare facilities and providers, impacting their ability to offer these treatments or invest in the necessary infrastructure and training.
The issue of high costs in the intra-gastric balloons market requires collaborative efforts from healthcare stakeholders, including manufacturers, regulators, insurers, and healthcare providers. Strategies such as cost-effective manufacturing processes, reimbursement reforms, and investment in research and development to improve the affordability and accessibility of intra-gastric balloons can help mitigate these challenges and ensure that more patients can benefit from this innovative weight management solution.
Opportunities:
- Increasing awareness
- Non-surgical alternatives
- Collaborations and partnerships
-
Customization and personalization -In the context of the Global Intra-Gastric Balloons Market, customization and personalization play increasingly vital roles in meeting the diverse needs and preferences of patients. As healthcare moves towards more patient-centric approaches, customization and personalization are becoming essential components of intra-gastric balloon therapy.
Customization in the intra-gastric balloons market involves tailoring the treatment approach to individual patient characteristics such as age, gender, BMI, medical history, and lifestyle factors. Healthcare providers may customize the selection of intra-gastric balloon type (saline-filled or gas-filled), balloon size, and duration of treatment based on patient-specific considerations. For example, patients with certain medical conditions or anatomical factors may benefit more from one type of balloon over another, or they may require a different treatment duration for optimal results.
Personalization takes customization a step further by considering the unique preferences and goals of each patient. This may involve engaging patients in shared decision-making processes, discussing their expectations, and aligning treatment plans with their lifestyle and preferences. Personalization can extend beyond the choice of intra-gastric balloon to include additional support services such as dietary counseling, behavioral therapy, and exercise programs tailored to the individual needs of each patient.
Technological advancements are facilitating greater customization and personalization in the intra-gastric balloons market. For instance, advanced imaging techniques allow for more accurate sizing and placement of balloons, minimizing the risk of complications and optimizing treatment outcomes. Digital health platforms and mobile applications enable patients to track their progress, receive personalized recommendations, and communicate with healthcare providers remotely, enhancing the overall patient experience and adherence to treatment.
Ongoing research and development efforts are focused on developing innovative intra-gastric balloon technologies that offer greater flexibility, efficacy, and patient comfort. These advancements aim to further enhance the customization and personalization options available to patients, ultimately improving the effectiveness and long-term success of intra-gastric balloon therapy for weight management.
In summary, customization and personalization are integral aspects of the Global Intra-Gastric Balloons Market, empowering healthcare providers to tailor treatment approaches to the unique needs and preferences of individual patients. By embracing customization and personalization, the intra-gastric balloons market can deliver more effective and patient-centered solutions for weight management, ultimately improving patient outcomes and satisfaction.
Competitive Landscape Analysis
Key players in Global Intra-Gastric Balloons Market include.
- Allurion Technologies
- Apollo Endosurgery
- Districlass Medical
- Helioscopie Medical Implants
- Silimed
- Medsil
- Obalon Therapeutics
- ReShape Medical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Filling Materials
- Market Snapshot, By End User
- Market Snapshot, By Region
- Intra-Gastric Balloons Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Minimally invasive procedures
-
Rising awareness
-
Non-surgical weight loss
-
Increasing healthcare expenditure
-
- Restraints
-
Limited Reimbursement
-
Temporary Weight Loss
-
Patient Selection Criteria
-
High Costs
-
- Opportunities
-
Increasing awareness
-
Non-surgical alternatives
-
Collaborations and partnerships
-
Customization and personalization
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Intra-Gastric Balloons Market, By Product Type, 2021-2031 (USD Million)
- Single Intra-gastric Balloons
- Dual Intra-gastric Balloons
- Triple Intra-gastric Balloons
- Intra-Gastric Balloons Market, By Filling Materials, 2021-2031 (USD Million)
- Saline Filled Balloons
- Gas Filled Balloons
- Intra-Gastric Balloons Market, By End User, 2021-2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Intra-Gastric Balloons Market, By Geography, 2021-2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Intra-Gastric Balloons Market, By Product Type, 2021-2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Allurion Technologies
- Apollo Endosurgery
- Districlass Medical
- Helioscopie Medical Implants
- Silimed
- Medsil
- Obalon Therapeutics
- ReShape Medical
- Company Profiles
- Analyst Views
- Future Outlook of the Market